BlackRock’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,425,234
| Closed | -$5.77M | – | 5459 |
|
|
2023
Q4 | $5.77M | Buy |
1,425,234
+84,754
| +6% | +$259K | ﹤0.01% | 3635 |
|
|
2023
Q3 | $3.61M | Buy |
1,340,480
+6,612
| +0.5% | +$25.9K | ﹤0.01% | 3792 |
|
|
2023
Q2 | $12.4M | Buy |
1,333,868
+450,406
| +51% | +$4.44M | ﹤0.01% | 3307 |
|
|
2023
Q1 | $7.85M | Buy |
883,462
+18,405
| +2% | +$181K | ﹤0.01% | 3442 |
|
|
2022
Q4 | $4.31M | Buy |
865,057
+89,467
| +12% | +$524K | ﹤0.01% | 3792 |
|
|
2022
Q3 | $4.5M | Buy |
775,590
+88,231
| +13% | +$623K | ﹤0.01% | 3805 |
|
|
2022
Q2 | $3.8M | Buy |
687,359
+142,504
| +26% | +$1.18M | ﹤0.01% | 3948 |
|
|
2022
Q1 | $6.28M | Buy |
544,855
+11,592
| +2% | +$124K | ﹤0.01% | 3832 |
|
|
2021
Q4 | $6.76M | Buy |
+533,263
| New | +$8.05M | ﹤0.01% | 3871 |
|